Hematology
| 3 min read
AbbVie announces ibrutinib plus rituximab approval by U.S. FDA as first chemotherapy-free combination treatment in adults with Waldenström's macroglobulinemia
| 4 min read
China National Drug Administration grants rapid approval of Roche’s alectinib as a treatment for ALK-positive lung cancer
| 5 min read
Broad Institute researchers say cancer cell lines evolve in ways that affect drug response
| 3 min read
The companies will work to incorporate PerkinElmer's LabChip GX Touch into Agena's MassARRAY system
| 3 min read
Q BioMed Inc. announces FDA filing for Strontium Chloride Sr89 Injection USP for relief of metastatic cancer bone pain
| 2 min read
Avista Healthcare Public Acquisition Corp. to combine with Organogenesis Inc.
| 3 min read
Progenics shares data supporting imaging analysis technology in prostate cancer
| 2 min read
Evidence shows patients benefit from molecular profiling
| 3 min read
Biotargeting system aims to drive clinical trial success in cancer studies
| 3 min read
Regeneron and bluebird bio announce collaboration to discover, develop and commercialize new cell therapies for cancer
| 2 min read
Genprex enters agreement with the University of Texas MD Anderson Cancer Center to study Oncoprex in combination with immunotherapies
| 3 min read
Results showed significant improvement: lower median number of sickle cell crises, fewer hospitalizations, lower cumulative days in hospital, and lower incidence of acute chest syndrome
